Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation

Michael Strebl1, Anis Arache1, Michaela Blech1

  • 1Boehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, PDB-TIP, Birkendorfer Straße 65, D-88397 Biberach an der Riss, Germany.

Related Concept Videos